RAPP EPS Estimates
Rapport Therapeutics, Inc. Common Stock
$28.33
-$0.66(-2.28%)
31
Overall
55
Value
9
Tech
31
Quality
Market Cap
$1.36B
Volume
304.01K
52W Range
$23.75 - $52.93
Target Price
$61.92
RAPP EPS estimates: the consensus estimate for Rapport Therapeutics, Inc. Common Stock's current fiscal year is -$4.09 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
RAPP EPS Estimates
- EPS estimate, current quarter
- $-1.21
- EPS estimate, next quarter
- $-1.21
- EPS estimate, current year
- $-4.09
- EPS estimate, next year
- $-4.92
- EPS growth, 3-year
- +64.81%
| Fiscal year | EPS |
|---|---|
| 2025 | $-2.86 |
| 2024 | $-3.78 |
| 2023 | $-23.10 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RAPP | $28.33 | -2.3% | 304.01K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Rapport Therapeutics, Inc. Common Stock Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW